List of most profitable companies in Major Pharmaceutical Preparations Industry over the past 12 months
|
| Company |
12 Months Ending from the most recent quarter |
Net Income In millions $ |
Net Income Margin |
Gross Profit Margin |
ROE |
| Johnson and Johnson |
3 Q |
$
25,119.00 |
27.26% |
68.08% |
32.69% |
| Eli Lilly And Company |
3 Q |
$
18,412.10 |
30.99% |
83.03% |
101.84% |
| Merck and Co Inc |
2 Q |
$
16,418.00 |
25.81% |
76.6% |
34.86% |
| Novartis Ag |
4 Q |
$
14,854.00 |
31.83% |
73.27% |
31.77% |
| Abbott Laboratories |
3 Q |
$
13,977.00 |
31.88% |
55.89% |
37.92% |
| Pfizer Inc |
3 Q |
$
9,869.00 |
15.72% |
73.39% |
10.93% |
| Sanofi |
4 Q |
$
6,292.16 |
12.69% |
70.18% |
7.22% |
| Bristol myers Squibb Company |
3 Q |
$
6,046.00 |
12.59% |
69.5% |
34.59% |
| Astrazeneca Plc |
4 Q |
$
5,961.00 |
13.01% |
81.95% |
15.22% |
| Regeneron Pharmaceuticals Inc |
3 Q |
$
4,578.00 |
32.13% |
91.94% |
15.31% |
| Vertex Pharmaceuticals Inc |
2 Q |
$
3,637.60 |
31.86% |
86.11% |
22.14% |
| Zoetis Inc |
3 Q |
$
2,651.00 |
28.21% |
71.68% |
53.56% |
| Abbvie Inc |
3 Q |
$
2,395.00 |
4.02% |
69.74% |
458.59% |
| Royalty Pharma Plc |
3 Q |
$
2,018.35 |
86.41% |
96.76% |
20.18% |
| United Therapeutics Corporation |
3 Q |
$
1,271.70 |
40.65% |
88.59% |
18.83% |
| Takeda Pharmaceutical Company Limited |
1 Q |
$
986.39 |
3.38% |
66.54% |
1.98% |
| Ptc Therapeutics inc |
3 Q |
$
877.74 |
97.52% |
- |
- |
| Organon and Co |
1 Q |
$
750.00 |
11.92% |
57.18% |
181.71% |
| Agios Pharmaceuticals Inc |
4 Q |
$
673.73 |
- |
88.59% |
58.94% |
| Dr Reddy s Laboratories Limited |
1 Q |
$
668.00 |
19.94% |
58.6% |
19.85% |
| Biomarin Pharmaceutical Inc |
3 Q |
$
520.42 |
16.82% |
81.32% |
8.84% |
| Prestige Consumer Healthcare Inc |
3 Q |
$
485.86 |
43.77% |
56.12% |
26.61% |
| Horizon Therapeutics Public Limited Company |
2 Q |
$
438.00 |
12.02% |
75.23% |
8.54% |
| Alkermes Plc |
3 Q |
$
338.83 |
22.27% |
86.04% |
21.4% |
| Bausch Health Companies Inc |
3 Q |
$
321.00 |
3.2% |
71.31% |
- |
| Acadia Pharmaceuticals Inc |
3 Q |
$
261.17 |
24.94% |
91.92% |
33.9% |
| Galapagos Nv |
4 Q |
$
237.10 |
88.31% |
- |
7.57% |
| Catalyst Pharmaceuticals Inc |
2 Q |
$
208.67 |
37.36% |
85.78% |
27.47% |
| Grifols Sa |
4 Q |
$
202.35 |
- |
- |
2.27% |
| Harmony Biosciences Holdings inc |
3 Q |
$
185.68 |
22.51% |
77.81% |
24.86% |
| Emergent Biosolutions Inc |
2 Q |
$
139.50 |
16.38% |
- |
26.83% |
| Corcept Therapeutics Inc |
2 Q |
$
132.00 |
18.43% |
98.37% |
20.02% |
| Arcutis Biotherapeutics Inc |
3 Q |
$
118.96 |
42.31% |
89.36% |
77.38% |
| Indivior Plc |
3 Q |
$
109.00 |
5.27% |
80.17% |
- |
| Amphastar Pharmaceuticals Inc |
3 Q |
$
100.36 |
13.84% |
47.41% |
13.3% |
| Rigel Pharmaceuticals Inc |
2 Q |
$
97.82 |
36.51% |
91.52% |
438.89% |
| Point Biopharma Global Inc |
3 Q |
$
96.55 |
39.62% |
- |
21.1% |
| Siga Technologies Inc |
3 Q |
$
74.47 |
43.23% |
76.29% |
35.26% |
| Aurinia Pharmaceuticals Inc |
2 Q |
$
60.64 |
23.31% |
89.51% |
16.72% |
| Tg Therapeutics Inc |
2 Q |
$
60.46 |
13.31% |
86.96% |
26.05% |
| Cryoport inc |
3 Q |
$
59.58 |
31.31% |
46.58% |
13.03% |
| Ocean Biomedical Inc |
1 Q |
$
58.86 |
- |
- |
- |
| Collegium Pharmaceutical inc |
3 Q |
$
58.44 |
9.89% |
73.27% |
24.09% |
| Abeona Therapeutics Inc |
2 Q |
$
57.24 |
- |
- |
77.68% |
| Third Harmonic Bio Inc |
1 Q |
$
53.45 |
- |
- |
19.27% |
| Stoke Therapeutics Inc |
2 Q |
$
52.48 |
26.26% |
- |
18.32% |
| Aeon Biopharma inc |
2 Q |
$
48.79 |
- |
- |
- |
| Entrada Therapeutics Inc |
1 Q |
$
48.59 |
28.21% |
- |
11.44% |
| Phibro Animal Health Corporation |
2 Q |
$
48.26 |
3.72% |
30.86% |
18.26% |
| Cytomx Therapeutics Inc |
2 Q |
$
47.98 |
34.01% |
- |
158.55% |
| Protagonist Therapeutics inc |
3 Q |
$
47.47 |
22.78% |
- |
7.47% |
| Apellis Pharmaceuticals Inc |
3 Q |
$
44.99 |
4.43% |
- |
18.94% |
| Amneal Pharmaceuticals Inc |
2 Q |
$
43.00 |
1.47% |
37.22% |
- |
| Ani Pharmaceuticals Inc |
3 Q |
$
40.57 |
4.91% |
61.14% |
9.2% |
| Innoviva Inc |
2 Q |
$
38.65 |
10.42% |
90.53% |
5.68% |
| Hutchmed china Limited |
4 Q |
$
38.17 |
6.06% |
44.64% |
4.95% |
| Puma Biotechnology Inc |
3 Q |
$
36.98 |
17.44% |
76.91% |
36.14% |
| Xeris Biopharma Holdings Inc |
2 Q |
$
36.17 |
14.7% |
82.24% |
- |
| Elanco Animal Health Incorporated |
3 Q |
$
36.00 |
0.78% |
54.96% |
0.55% |
| Kiniksa Pharmaceuticals International Plc |
3 Q |
$
35.92 |
6.01% |
87.52% |
7.46% |
| Zevra Therapeutics Inc |
3 Q |
$
35.33 |
41.86% |
80.65% |
42.68% |
| Orgenesis Inc |
3 Q |
$
35.26 |
- |
-88.78% |
- |
| Mannkind Corporation |
3 Q |
$
29.23 |
9.32% |
80.81% |
- |
| Taro Pharmaceutical Industries Ltd |
1 Q |
$
25.45 |
4.44% |
46.83% |
1.47% |
| Redhill Biopharma Ltd |
4 Q |
$
23.92 |
- |
47.03% |
1155.92% |
| Thorne Healthtech Inc |
2 Q |
$
19.79 |
7.73% |
50.15% |
13.58% |
| Landos Biopharma Inc |
4 Q |
$
19.54 |
- |
- |
48.49% |
| Nature s Sunshine Products inc |
3 Q |
$
15.21 |
3.21% |
72.36% |
9.24% |
| Chemomab Therapeutics Ltd |
4 Q |
$
13.95 |
- |
- |
103.01% |
| Theravance Biopharma inc |
2 Q |
$
13.03 |
16.88% |
- |
6.93% |
| Eagle Pharmaceuticals inc |
2 Q |
$
11.95 |
4.64% |
71.55% |
4.98% |
| Cormedix Inc |
2 Q |
$
11.64 |
13.99% |
93.93% |
11.35% |
| Lifevantage Corp |
2 Q |
$
9.81 |
4.31% |
80.67% |
31.07% |
| Gyre Therapeutics Inc |
2 Q |
$
8.74 |
8.55% |
95.91% |
8.11% |
| Kamada Ltd |
4 Q |
$
8.28 |
5.81% |
38.94% |
3.39% |
| Galmed Pharmaceuticals Ltd |
4 Q |
$
7.52 |
- |
- |
46.04% |
| Guardion Health Sciences Inc |
2 Q |
$
6.37 |
70.35% |
44.42% |
77.24% |
| Synlogic Inc |
2 Q |
$
5.98 |
- |
- |
46.41% |
| Lipocine Inc |
2 Q |
$
5.66 |
37.85% |
- |
29.6% |
| Seres Therapeutics Inc |
3 Q |
$
5.39 |
40.33% |
- |
15.31% |
| Keros Therapeutics Inc |
1 Q |
$
4.21 |
1.76% |
- |
0.75% |
| Seelos Therapeutics inc |
2 Q |
$
4.09 |
- |
- |
- |
| Earth Science Tech Inc |
2 Q |
$
2.65 |
8.33% |
75.36% |
72.52% |
| Bellicum Pharmaceuticals Inc |
3 Q |
$
2.59 |
- |
- |
- |
| Novabay Pharmaceuticals Inc |
2 Q |
$
2.32 |
24.46% |
68.36% |
81.69% |
| Viveon Health Acquisition Corp |
1 Q |
$
1.18 |
- |
- |
- |
| American Bio Medica Corporation |
1 Q |
$
0.85 |
- |
-7.85% |
- |
| Integrated Biopharma Inc |
2 Q |
$
0.81 |
1.51% |
10.38% |
4.04% |
| Rebus Holdings Inc |
2 Q |
$
0.57 |
- |
- |
- |
| Rapid Therapeutic Science Laboratories Inc |
2 Q |
$
0.06 |
- |
- |
- |
| Aardvark Therapeutics Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Alumis inc |
2 Q |
$
0.00 |
- |
- |
- |
| Apollomics Inc |
4 Q |
$
0.00 |
- |
- |
0% |
| Aspire Biopharma Holdings Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Alterity Therapeutics Limited |
2 Q |
$
0.00 |
- |
- |
0% |
| Crescent Biopharma Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Curanex Pharmaceuticals Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Elevai Labs Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Tuhura Biosciences Inc |
2 Q |
$
0.00 |
- |
- |
0% |
| Hyperion Defi inc |
2 Q |
$
0.00 |
- |
- |
- |
| Opus Genetics Inc |
2 Q |
$
0.00 |
- |
- |
0% |
| Jade Biosciences Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Jupiter Neurosciences Inc |
2 Q |
$
0.00 |
- |
- |
0% |
| Lite Strategy Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Lava Therapeutics Nv |
2 Q |
$
0.00 |
- |
- |
- |
| Medicus Pharma Ltd |
2 Q |
$
0.00 |
- |
- |
- |
| Metsera Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Metavia Inc |
2 Q |
$
0.00 |
- |
- |
0% |
| Neurosense Therapeutics Ltd |
4 Q |
$
0.00 |
- |
- |
- |
| Neonc Technologies Holdings Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Beigene Ltd |
1 Q |
$
0.00 |
- |
- |
0% |
| Proqr Therapeutics N v |
4 Q |
$
0.00 |
- |
- |
0% |
| Palvella Therapeutics Inc |
2 Q |
$
0.00 |
- |
- |
0% |
| Rein Therapeutics Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Rayzebio Inc |
3 Q |
$
0.00 |
- |
- |
- |
| Sionna Therapeutics Inc |
3 Q |
$
0.00 |
- |
- |
- |
| Spruce Biosciences Inc |
2 Q |
$
0.00 |
- |
- |
- |
| 60 Degrees Pharmaceuticals Inc |
3 Q |
$
0.00 |
- |
- |
- |
| Tao Synergies Inc |
2 Q |
$
0.00 |
- |
- |
- |
| Whitehawk Therapeutics Inc |
3 Q |
$
0.00 |
- |
- |
0% |
| Clearmind Medicine Inc |
1 Q |
$
-0.02 |
- |
- |
- |
| Hst Global Inc |
3 Q |
$
-0.10 |
- |
- |
-1010.9% |
| Sangui Biotech International Inc |
1 Q |
$
-0.13 |
-156.65% |
- |
- |
| Nexien Biopharma Inc |
1 Q |
$
-0.19 |
- |
- |
- |
| Cnbx Pharmaceuticals Inc |
2 Q |
$
-0.22 |
-41.55% |
98.85% |
- |
| International Stem Cell Corporation |
1 Q |
$
-0.25 |
-2.76% |
57.41% |
- |
| Procyon Corporation |
2 Q |
$
-0.28 |
-5.71% |
78.07% |
-12.01% |
| Neuphoria Therapeutics Inc |
2 Q |
$
-0.37 |
- |
- |
-1.95% |
| Protokinetix Incorporated |
2 Q |
$
-0.38 |
- |
- |
-104.74% |
| Actavia Life Sciences Inc |
1 Q |
$
-0.41 |
-333.15% |
- |
- |
| Skinvisible Inc |
2 Q |
$
-0.53 |
-2636.33% |
- |
- |
| Avricore Health Inc |
4 Q |
$
-0.54 |
-27.95% |
47.97% |
-34.9% |
| The Greater Cannabis Company Inc |
2 Q |
$
-0.58 |
- |
- |
- |
| Denali Capital Acquisition Corp |
1 Q |
$
-0.65 |
- |
- |
- |
| Bioadaptives Inc |
2 Q |
$
-0.76 |
-4485.64% |
42.47% |
- |
| Lftd Partners Inc |
2 Q |
$
-0.77 |
-2.09% |
30.8% |
-2.05% |
| Regen Biopharma Inc |
2 Q |
$
-0.78 |
-267.99% |
- |
- |
| Xtl Biopharmaceuticals Ltd |
4 Q |
$
-0.78 |
- |
- |
-35.23% |
| Medicure Inc |
4 Q |
$
-0.80 |
-4.74% |
59.75% |
-5% |
| Lianbio |
3 Q |
$
-0.87 |
- |
- |
-0.33% |
| Globestar Therapeutics Corporation |
2 Q |
$
-0.89 |
- |
- |
- |
| Bespoke Extracts Inc |
2 Q |
$
-0.93 |
-75.3% |
44.83% |
- |
| China Health Industries Holdings Inc |
1 Q |
$
-1.36 |
-2215.98% |
64.81% |
-7.45% |
| Q Biomed inc |
1 Q |
$
-1.45 |
-511.07% |
-4.43% |
- |
| Bgm Group Ltd |
3 Q |
$
-1.52 |
-6.29% |
17.06% |
-3.44% |
| Accustem Sciences Inc |
2 Q |
$
-1.54 |
- |
- |
- |
| Cv Sciences Inc |
2 Q |
$
-1.55 |
-11.98% |
53.69% |
-80.82% |
| Revance Therapeutics Inc |
3 Q |
$
-1.63 |
-0.66% |
73.44% |
- |
| Regenerx Biopharmaceuticals inc |
1 Q |
$
-1.69 |
-2199.83% |
- |
- |
| Therapeuticsmd Inc |
2 Q |
$
-1.80 |
-84.71% |
99.62% |
-6.62% |
| Renovorx Inc |
2 Q |
$
-1.85 |
- |
- |
-20.94% |
| Biostax Corp |
3 Q |
$
-1.87 |
- |
- |
- |
| Novaccess Global Inc |
2 Q |
$
-1.89 |
- |
- |
- |
| Nascent Biotech Inc |
2 Q |
$
-1.92 |
-659194.52% |
- |
- |
| Cyclerion Therapeutics Inc |
2 Q |
$
-1.95 |
-89.51% |
- |
-22.63% |
| One World Products Inc |
2 Q |
$
-1.95 |
-39160.5% |
79.96% |
- |
| Fibrogen Inc |
2 Q |
$
-2.07 |
-1.15% |
-55.07% |
- |
| Rockwell Medical inc |
2 Q |
$
-2.10 |
-2.4% |
17.63% |
-6.79% |
| Emmis Acquisition Corp |
2 Q |
$
-2.15 |
-205.75% |
-43.2% |
- |
| Xortx Therapeutics inc |
4 Q |
$
-2.16 |
-234.7% |
- |
-16.83% |
| Bioxytran Inc |
2 Q |
$
-2.22 |
- |
- |
- |
| Innovation Pharmaceuticals Inc |
3 Q |
$
-2.62 |
- |
- |
-116.47% |
| Kairos Pharma Ltd |
2 Q |
$
-2.68 |
- |
- |
-50.55% |
| Adhera Therapeutics Inc |
2 Q |
$
-2.75 |
-0.1% |
2.73% |
- |
| Avenir Wellness Solutions Inc |
3 Q |
$
-2.76 |
-90.22% |
46.89% |
- |
| Inmed Pharmaceuticals Inc |
3 Q |
$
-2.91 |
-41.77% |
27.96% |
-27.18% |
| Avadel Pharmaceuticals Plc |
2 Q |
$
-2.92 |
-1.32% |
89.6% |
-3.73% |
| Cumberland Pharmaceuticals Inc |
2 Q |
$
-2.93 |
-6.95% |
83.99% |
-11.36% |
| Merrimack Pharmaceuticals Inc |
1 Q |
$
-3.03 |
- |
- |
-4.35% |
| Xenetic Biosciences Inc |
2 Q |
$
-3.08 |
-126.03% |
- |
-54.53% |
| Lixte Biotechnology Holdings Inc |
2 Q |
$
-3.09 |
- |
- |
-308.53% |
| Respirerx Pharmaceuticals Inc |
2 Q |
$
-3.40 |
- |
- |
- |
| Inhibitor Therapeutics Inc |
2 Q |
$
-3.45 |
- |
- |
-184.76% |
| Durect Corp |
2 Q |
$
-3.48 |
-40.47% |
-32.57% |
-72.53% |
| Petros Pharmaceuticals inc |
2 Q |
$
-3.56 |
-81.06% |
63.33% |
-47.5% |
| China Pharma Holdings Inc |
2 Q |
$
-3.66 |
-83.17% |
-20.55% |
-52.78% |
| Lucy Scientific Discovery Inc |
4 Q |
$
-3.68 |
- |
- |
-109.81% |
| Immuron Limited |
2 Q |
$
-3.79 |
-255.78% |
88.43% |
-19.3% |
| Alaunos Therapeutics Inc |
2 Q |
$
-3.99 |
- |
- |
-167.98% |
| 2seventy Bio Inc |
1 Q |
$
-4.09 |
-8.46% |
- |
-1.84% |
| Eton Pharmaceuticals Inc |
2 Q |
$
-4.13 |
-7.05% |
59.02% |
-18.59% |
| Axim Biotechnologies Inc |
2 Q |
$
-4.14 |
-4463.98% |
98.12% |
- |
| Oncotelic Therapeutics Inc |
2 Q |
$
-4.18 |
- |
- |
-55.39% |
| Aptorum Group Limited |
4 Q |
$
-4.34 |
-1006.3% |
2.45% |
-28.22% |
| Emmaus Life Sciences Inc |
1 Q |
$
-4.44 |
-27.12% |
94.08% |
- |
| Reshape Lifesciences Inc |
2 Q |
$
-4.50 |
-81.74% |
73.38% |
-216.95% |
| Incannex Healthcare Inc |
1 Q |
$
-4.62 |
- |
- |
-54.81% |
| Abvc Biopharma Inc |
3 Q |
$
-4.70 |
-897.57% |
94.2% |
-47.08% |
| Silo Pharma Inc |
2 Q |
$
-4.90 |
-6789.22% |
91.9% |
-94.39% |
| Salarius Pharmaceuticals inc |
2 Q |
$
-5.10 |
-108.64% |
- |
-556.47% |
| Protagenic Therapeutics Inc new |
1 Q |
$
-5.24 |
- |
- |
-860.48% |
| Innovation1 Biotech Inc |
1 Q |
$
-5.30 |
-6727.77% |
3.4% |
- |
| Cell Source Inc |
3 Q |
$
-5.32 |
- |
- |
- |
| Evoke Pharma Inc |
2 Q |
$
-5.38 |
-42.07% |
- |
-99.48% |
| Lipella Pharmaceuticals Inc |
2 Q |
$
-5.52 |
-1174.13% |
- |
-216.5% |
| Bright Minds Biosciences Inc |
3 Q |
$
-5.65 |
- |
- |
-111.73% |
| Cannapharmarx Inc |
2 Q |
$
-5.66 |
-415.54% |
-266.04% |
- |
| Actuate Therapeutics Inc |
2 Q |
$
-5.69 |
- |
- |
- |
| Kaya Holdings Inc |
2 Q |
$
-5.76 |
- |
- |
- |
| Edesa Biotech Inc |
2 Q |
$
-5.92 |
- |
- |
-69.81% |
| Universe Pharmaceuticals Inc |
3 Q |
$
-6.16 |
-19.08% |
31.93% |
-15.59% |
| Evofem Biosciences Inc |
2 Q |
$
-6.25 |
-36.16% |
79.73% |
- |
| Sunshine Biopharma Inc |
2 Q |
$
-6.31 |
-17.35% |
33.33% |
-26.03% |
| Igc Pharma Inc |
2 Q |
$
-6.34 |
-477.92% |
45.97% |
-97.4% |
| Cyclacel Pharmaceuticals Inc |
2 Q |
$
-6.41 |
-160200% |
- |
-722.23% |
| Provectus Biopharmaceuticals Inc |
2 Q |
$
-6.42 |
-1368.45% |
- |
- |
| Veru Inc |
2 Q |
$
-6.44 |
-38.21% |
34.73% |
-27.02% |
| Ensysce Biosciences Inc |
2 Q |
$
-6.58 |
-88.78% |
- |
-167.26% |
| Alzamend Neuro Inc |
2 Q |
$
-6.83 |
- |
- |
-165.51% |
| Bullfrog Ai Holdings Inc |
2 Q |
$
-6.94 |
- |
- |
-195.32% |
| Qualigen Therapeutics Inc |
2 Q |
$
-6.98 |
-145.82% |
- |
- |
| Biofrontera Inc |
2 Q |
$
-7.01 |
-9.26% |
74.42% |
-486.61% |
| Biodexa Pharmaceuticals Plc |
4 Q |
$
-7.08 |
-1858.01% |
- |
-151.33% |
| Phio Pharmaceuticals Corp |
2 Q |
$
-7.09 |
- |
- |
-88.75% |
| Baudax Bio Inc |
3 Q |
$
-7.16 |
-563.83% |
-452.32% |
- |
| Pulmatrix Inc |
3 Q |
$
-7.26 |
-92.98% |
- |
-91.45% |
| 180 Life Sciences Corp |
1 Q |
$
-7.47 |
- |
- |
-147.34% |
| Mira Pharmaceuticals Inc |
2 Q |
$
-7.77 |
- |
- |
-406.68% |
| Can Fite Biopharma Ltd |
4 Q |
$
-7.88 |
-1169.14% |
- |
-144.96% |
| Exicure Inc |
2 Q |
$
-7.88 |
-115.82% |
- |
-110.4% |
| Ironwood Pharmaceuticals inc |
2 Q |
$
-7.89 |
-2.56% |
- |
- |
| Zyversa Therapeutics Inc |
2 Q |
$
-8.29 |
- |
- |
-111.39% |
| Promis Neurosciences inc |
2 Q |
$
-8.43 |
- |
- |
-102.61% |
| Adial Pharmaceuticals Inc |
2 Q |
$
-8.45 |
- |
- |
-191.29% |
| Kineta Inc |
1 Q |
$
-8.46 |
- |
- |
- |
| Anebulo Pharmaceuticals Inc |
2 Q |
$
-8.48 |
- |
- |
-80.84% |
| Kiora Pharmaceuticals Inc |
3 Q |
$
-8.54 |
- |
- |
-36.35% |
| Ampio Pharmaceuticals inc |
4 Q |
$
-8.63 |
-17264% |
0% |
-149% |
| Journey Medical Corp |
2 Q |
$
-8.74 |
-15.49% |
69.41% |
-48.69% |
| Bellerophon Therapeutics inc |
3 Q |
$
-9.25 |
- |
- |
-164.63% |
| Scopus Biopharma Inc |
2 Q |
$
-9.34 |
- |
- |
- |
| Azitra Inc |
2 Q |
$
-9.36 |
- |
- |
-183.59% |
| Avenue Therapeutics Inc |
2 Q |
$
-9.39 |
- |
- |
-433.07% |
| Gt Biopharma Inc |
2 Q |
$
-9.40 |
- |
- |
-1628.25% |
| Nanoviricides inc |
2 Q |
$
-9.47 |
- |
- |
-102.78% |
| Enveric Biosciences Inc |
2 Q |
$
-9.94 |
- |
- |
-341.49% |
| Acurx Pharmaceuticals inc |
2 Q |
$
-10.00 |
- |
- |
-436.78% |
| Gri Bio Inc |
2 Q |
$
-10.01 |
- |
- |
-327.62% |
| Hoth Therapeutics Inc |
2 Q |
$
-10.19 |
- |
- |
-114.32% |
| Harrow Inc |
2 Q |
$
-10.23 |
-4.49% |
74.53% |
-17.61% |
| Oragenics Inc |
2 Q |
$
-10.30 |
-4714.25% |
- |
-4705.41% |
| Dermata Therapeutics Inc |
2 Q |
$
-10.33 |
- |
- |
-214.98% |
| Artelo Biosciences Inc |
2 Q |
$
-10.50 |
- |
- |
-496.36% |
| Pharming Group N v |
1 Q |
$
-10.55 |
-4.3% |
89.8% |
-5.39% |
| Addex Therapeutics Ltd |
4 Q |
$
-10.56 |
-654.47% |
- |
-921.57% |
| Sol gel Technologies Ltd |
4 Q |
$
-10.58 |
-91.7% |
- |
-36.67% |
| Soligenix inc |
2 Q |
$
-10.65 |
-1253.36% |
17.87% |
-274.82% |
| Elite Pharmaceuticals Inc |
2 Q |
$
-10.82 |
-10.42% |
56.66% |
-23.4% |
| Organigram Holdings Inc |
3 Q |
$
-10.94 |
-9.8% |
21.65% |
-5.26% |
| Tenax Therapeutics Inc |
2 Q |
$
-11.03 |
- |
- |
-10.98% |
| Anixa Biosciences Inc |
2 Q |
$
-11.22 |
- |
- |
-68.08% |
| Intelgenx Technologies Corp |
1 Q |
$
-11.28 |
-1053.03% |
-21.76% |
- |
| Talphera Inc |
2 Q |
$
-11.31 |
-743.26% |
-127.68% |
-151.4% |
| Lexaria Bioscience Corp |
2 Q |
$
-11.40 |
-1851.01% |
99.56% |
-157.36% |
| Galera Therapeutics Inc |
2 Q |
$
-11.49 |
- |
- |
- |
| Revelation Biosciences Inc |
2 Q |
$
-11.64 |
- |
- |
-330.61% |
| Medicinova Inc |
2 Q |
$
-11.81 |
- |
- |
-23.12% |
| Comera Life Sciences Holdings Inc |
3 Q |
$
-11.89 |
-1084.99% |
71.76% |
- |
| Tharimmune Inc |
2 Q |
$
-11.93 |
- |
- |
-1230.82% |
| Virpax Pharmaceuticals Inc |
4 Q |
$
-12.07 |
- |
- |
- |
| Shuttle Pharmaceuticals Holdings Inc |
2 Q |
$
-12.14 |
- |
- |
-772.82% |
| Quoin Pharmaceuticals Ltd |
2 Q |
$
-12.17 |
- |
- |
-210.51% |
| Nls Pharmaceutics Ltd |
4 Q |
$
-12.17 |
- |
- |
- |
| Akari Therapeutics Plc |
2 Q |
$
-12.27 |
- |
- |
-78.03% |
| Bio path Holdings inc |
2 Q |
$
-12.32 |
- |
- |
- |
| Citius Oncology Inc |
2 Q |
$
-12.36 |
- |
- |
-79.07% |
| Histogen Inc |
3 Q |
$
-12.38 |
-65173.68% |
- |
-136.2% |
| Greenwich Lifesciences Inc |
2 Q |
$
-12.56 |
- |
- |
-369.11% |
| Cocrystal Pharma Inc |
2 Q |
$
-12.56 |
-623.68% |
- |
-144.12% |
| Cohbar Inc |
2 Q |
$
-12.69 |
- |
- |
-88.89% |
| Processa Pharmaceuticals Inc |
2 Q |
$
-12.88 |
- |
- |
-342.35% |
| Equillium Inc |
2 Q |
$
-12.96 |
-31.53% |
- |
-89.55% |
| Societal Cdmo Inc |
4 Q |
$
-13.27 |
-14.03% |
19.17% |
-23.37% |
| Cadrenal Therapeutics Inc |
2 Q |
$
-13.28 |
- |
- |
-277.54% |
| Grace Therapeutics Inc |
4 Q |
$
-13.37 |
- |
- |
-23.32% |
| Sonnet Biotherapeutics Holdings Inc |
2 Q |
$
-13.56 |
-3873.84% |
- |
-4648.06% |
| Hepion Pharmaceuticals Inc |
2 Q |
$
-13.56 |
- |
- |
-1000.33% |
| Aytu Biopharma Inc |
2 Q |
$
-13.56 |
-20.6% |
69.62% |
-47.4% |
| Heron Therapeutics Inc |
3 Q |
$
-13.58 |
-8.84% |
74.62% |
- |
| Pasithea Therapeutics Corp |
2 Q |
$
-13.71 |
-2817.86% |
76.74% |
-90.27% |
| Neubase Therapeutics inc |
3 Q |
$
-13.73 |
- |
- |
-103.52% |
| Aprea Therapeutics Inc |
2 Q |
$
-13.85 |
- |
- |
-78.9% |
| Minerva Neurosciences Inc |
3 Q |
$
-14.03 |
- |
- |
- |
| Quantum Biopharma Ltd |
4 Q |
$
-14.20 |
-311.75% |
- |
-136.04% |
| Alt5 Sigma Corporation |
2 Q |
$
-14.37 |
-69.87% |
51.37% |
-61.85% |
| Biovie Inc |
2 Q |
$
-14.42 |
- |
- |
-79.52% |
| Painreform Ltd |
4 Q |
$
-14.59 |
- |
- |
-799.78% |
| Marker Therapeutics inc |
2 Q |
$
-14.61 |
-271.11% |
- |
-114.59% |
| Xoma Royalty Corporation |
2 Q |
$
-14.70 |
-32.69% |
- |
-18.15% |
| Alimera Sciences Inc |
2 Q |
$
-14.70 |
-14.98% |
87.79% |
-33.7% |
| Organogenesis Holdings Inc |
2 Q |
$
-14.93 |
-3.47% |
81.01% |
-5.87% |
| Timber Pharmaceuticals Inc |
2 Q |
$
-14.93 |
-1690.66% |
- |
-516.88% |
| Cns Pharmaceuticals Inc |
2 Q |
$
-15.46 |
-44914.23% |
- |
-183.9% |
| Ainos Inc |
2 Q |
$
-15.72 |
-626.97% |
3.64% |
-108.25% |
| Imunon Inc |
2 Q |
$
-15.75 |
-3149.15% |
- |
-405.09% |
| Agile Therapeutics Inc |
2 Q |
$
-15.85 |
-80.39% |
69.59% |
- |
| Telomir Pharmaceuticals Inc |
2 Q |
$
-16.08 |
- |
- |
-4576.86% |
| Maia Biotechnology Inc |
2 Q |
$
-16.17 |
- |
- |
-459.68% |
| Os Therapies Incoporated |
2 Q |
$
-16.25 |
- |
- |
- |
| Aeterna Zentaris Inc |
4 Q |
$
-16.55 |
-367.99% |
95.06% |
-31.24% |
| Galecto Inc |
2 Q |
$
-16.59 |
- |
- |
-108.05% |
| Indaptus Therapeutics Inc |
2 Q |
$
-16.96 |
- |
- |
-612.63% |
| Dar Bioscience Inc |
2 Q |
$
-17.15 |
-106362.11% |
- |
- |
| Palatin Technologies Inc |
2 Q |
$
-17.31 |
-794.41% |
86.05% |
- |
| Monopar Therapeutics Inc |
2 Q |
$
-17.31 |
- |
- |
-41.76% |
| Genprex Inc |
2 Q |
$
-17.56 |
- |
- |
-822.22% |
| Paxmedica Inc |
2 Q |
$
-17.66 |
- |
- |
-3167.06% |
| Tiziana Life Sciences Ltd |
4 Q |
$
-17.69 |
- |
- |
-319.56% |
| Ayala Pharmaceuticals Inc |
3 Q |
$
-17.86 |
-477.59% |
93.32% |
-42.46% |
| Clever Leaves Holdings Inc |
4 Q |
$
-17.90 |
-108.11% |
39.6% |
-57.45% |
| Cingulate Inc |
2 Q |
$
-17.96 |
- |
- |
-232.16% |
| Tff Pharmaceuticals Inc |
3 Q |
$
-18.17 |
-1417.6% |
- |
-259.46% |
| Ibio inc |
2 Q |
$
-18.38 |
-871.36% |
67.19% |
-126.93% |
| Fibrobiologics Inc |
3 Q |
$
-18.50 |
- |
- |
-1219.18% |
| Gain Therapeutics inc |
2 Q |
$
-18.59 |
-8826.1% |
- |
-289.11% |
| Vaccinex Inc |
4 Q |
$
-18.63 |
- |
- |
- |
| Longeveron Inc |
2 Q |
$
-18.69 |
-901.59% |
78.73% |
-96.68% |
| Lisata Therapeutics Inc |
2 Q |
$
-18.92 |
- |
- |
-69.68% |
| Eledon Pharmaceuticals Inc |
1 Q |
$
-19.05 |
- |
- |
-25.37% |
| Biophytis Sa |
4 Q |
$
-19.07 |
- |
- |
- |
| Supernus Pharmaceuticals inc |
3 Q |
$
-19.12 |
-2.8% |
88.61% |
-1.83% |
| Lantern Pharma Inc |
2 Q |
$
-19.25 |
- |
- |
-99.88% |
| Scynexis Inc |
2 Q |
$
-19.52 |
-599.05% |
- |
-37.42% |
| Flora Growth Corp |
3 Q |
$
-19.58 |
-48.49% |
10.59% |
-100.13% |
| Matinas Biopharma Holdings Inc |
2 Q |
$
-19.61 |
-457.73% |
- |
-210.21% |
| Cdt Equity Inc |
2 Q |
$
-20.04 |
- |
- |
- |
| Scienture Holdings Inc |
2 Q |
$
-20.13 |
-13703.72% |
4.55% |
-24.91% |
| Coya Therapeutics Inc |
2 Q |
$
-20.34 |
- |
- |
-61.05% |
| Neximmune Inc |
2 Q |
$
-20.62 |
- |
- |
-542.45% |
| Immunoprecise Antibodies Ltd |
1 Q |
$
-20.82 |
-110.85% |
49.16% |
-80.12% |
| Calcimedica Inc |
2 Q |
$
-20.87 |
- |
- |
-206.51% |
| Tvardi Therapeutics Inc |
2 Q |
$
-20.89 |
- |
- |
-398.59% |
| Cytodyn inc |
3 Q |
$
-21.02 |
- |
- |
- |
| Oncolytics Biotech Inc |
4 Q |
$
-21.26 |
- |
- |
-100.69% |
| Hcw Biologics Inc |
2 Q |
$
-21.55 |
-2588% |
20% |
- |
| Y mabs Therapeutics inc |
2 Q |
$
-22.22 |
-26.23% |
82.43% |
-24.6% |
| I mab |
4 Q |
$
-22.23 |
-571.02% |
- |
-11.05% |
| Dmk Pharmaceuticals Corporation |
3 Q |
$
-22.23 |
-630.71% |
-38.3% |
- |
| Entero Therapeutics Inc |
2 Q |
$
-22.45 |
- |
- |
- |
| Cervomed Inc |
2 Q |
$
-22.61 |
-290.75% |
- |
-59.15% |
| Vincerx Pharma Inc |
1 Q |
$
-22.65 |
- |
- |
-308.66% |
| Immix Biopharma Inc |
2 Q |
$
-23.13 |
- |
- |
-205.35% |
| Notable Labs Ltd |
2 Q |
$
-23.76 |
- |
- |
-182.14% |
| Vtv Therapeutics Inc |
2 Q |
$
-23.87 |
-475.77% |
- |
-219.45% |
| Theratechnologies Inc |
4 Q |
$
-23.96 |
-29.3% |
75.99% |
- |
| Aptevo Therapeutics Inc |
2 Q |
$
-24.03 |
-185.02% |
- |
-675.52% |
| Iterum Therapeutics Plc |
2 Q |
$
-24.08 |
-168.12% |
-25.21% |
- |
| Contrafect Corporation |
3 Q |
$
-24.14 |
- |
- |
- |
| Oramed Pharmaceuticals Inc |
2 Q |
$
-24.18 |
-896.88% |
- |
-16.27% |
| Geovax Labs Inc |
1 Q |
$
-24.50 |
-438.17% |
- |
-511.98% |
| Transcode Therapeutics Inc |
2 Q |
$
-24.63 |
- |
- |
-612.92% |
| Allarity Therapeutics Inc |
2 Q |
$
-24.66 |
-103.64% |
2.12% |
-177.35% |
| Essa Pharma inc |
2 Q |
$
-25.27 |
-4205.63% |
- |
-21.7% |
| Unicycive Therapeutics Inc |
2 Q |
$
-25.63 |
- |
- |
-162.8% |
| Eupraxia Pharmaceuticals Inc |
4 Q |
$
-25.74 |
- |
- |
-80.86% |
| Sellas Life Sciences Group Inc |
2 Q |
$
-26.26 |
- |
- |
-132.51% |
| Mainz Biomed N v |
4 Q |
$
-26.30 |
-2936.5% |
56.91% |
-809.29% |
| Nuvectis Pharma inc |
3 Q |
$
-26.53 |
- |
- |
-148.29% |
| Altamira Therapeutics Ltd |
4 Q |
$
-26.53 |
-8680.31% |
-372.44% |
- |
| Moleculin Biotech Inc |
2 Q |
$
-26.55 |
- |
- |
-1676.4% |
| Briacell Therapeutics Corp |
2 Q |
$
-26.56 |
- |
- |
-293.32% |
| Kazia Therapeutics Limited |
2 Q |
$
-26.78 |
-1079.32% |
- |
-222.22% |
| Sensei Biotherapeutics Inc |
2 Q |
$
-26.82 |
- |
- |
-74.79% |
| Reviva Pharmaceuticals Holdings Inc |
2 Q |
$
-27.11 |
- |
- |
- |
| Theriva Biologics inc |
2 Q |
$
-27.24 |
- |
- |
-90.71% |
| Unity Biotechnology Inc |
1 Q |
$
-27.50 |
- |
- |
-273.74% |
| Nucana Plc |
4 Q |
$
-27.63 |
- |
- |
-185.61% |
| Context Therapeutics Inc |
1 Q |
$
-27.63 |
- |
- |
-29.78% |
| Serina Therapeutics Inc |
2 Q |
$
-27.67 |
-49407.14% |
- |
- |
| Clearside Biomedical Inc |
2 Q |
$
-27.71 |
-665.22% |
90.47% |
- |
| Panbela Therapeutics Inc |
3 Q |
$
-27.92 |
- |
- |
- |
| Xbiotech Inc |
2 Q |
$
-28.16 |
-343.03% |
79.52% |
-15.6% |
| Atossa Therapeutics Inc |
2 Q |
$
-28.72 |
- |
- |
-42.83% |
| Enlivex Therapeutics Ltd |
4 Q |
$
-29.07 |
- |
- |
-96.62% |
| Cellectar Biosciences Inc |
2 Q |
$
-29.07 |
- |
- |
-265.51% |
| Diamedica Therapeutics Inc |
2 Q |
$
-29.58 |
- |
- |
-78.98% |
| Clene Inc |
2 Q |
$
-29.71 |
-10386.36% |
80.42% |
- |
| Optinose Inc |
1 Q |
$
-29.89 |
-32.99% |
91.45% |
- |
| Sigilon Therapeutics Inc |
2 Q |
$
-30.24 |
-171.29% |
- |
-83.83% |
| Annovis Bio Inc |
2 Q |
$
-30.26 |
- |
- |
-206.01% |
| Rafael Holdings Inc |
2 Q |
$
-30.64 |
-3341.66% |
- |
-34.94% |
| Biora Therapeutics Inc |
3 Q |
$
-31.54 |
-15769.5% |
- |
- |
| Actinium Pharmaceuticals Inc |
2 Q |
$
-31.85 |
-2178.18% |
- |
-95.19% |
| Novan Inc |
1 Q |
$
-32.05 |
-128.61% |
66.06% |
-616.76% |
| Genelux Corporation |
2 Q |
$
-32.90 |
- |
- |
-116.33% |
| Cyteir Therapeutics Inc |
3 Q |
$
-33.22 |
-2.15% |
36.8% |
-24.88% |
| Adagene Inc |
4 Q |
$
-33.42 |
-32386.45% |
- |
-66.16% |
| Trevena inc |
3 Q |
$
-34.04 |
-9004.23% |
-391.8% |
- |
| Oncternal Therapeutics Inc |
3 Q |
$
-34.58 |
-1599.95% |
- |
-177.58% |
| Effector Therapeutics Inc |
1 Q |
$
-34.63 |
- |
- |
- |
| Nrx Pharmaceuticals Inc |
2 Q |
$
-34.81 |
- |
- |
- |
| Lumos Pharma Inc |
3 Q |
$
-34.92 |
-1583.49% |
- |
-233.03% |
| Gh Research Plc |
4 Q |
$
-35.59 |
- |
- |
-16.25% |
| Tempest Therapeutics Inc |
3 Q |
$
-36.05 |
- |
- |
-310.89% |
| Belite Bio Inc |
4 Q |
$
-36.14 |
- |
- |
-24.79% |
| Macrogenics Inc |
2 Q |
$
-36.40 |
-21.99% |
99.76% |
-40.24% |
| Pds Biotechnology Corp |
2 Q |
$
-36.48 |
- |
- |
-183.94% |
| Akebia Therapeutics Inc |
2 Q |
$
-36.48 |
-17.91% |
74.44% |
- |
| Alpine Immune Sciences Inc |
1 Q |
$
-36.84 |
-65.17% |
- |
-14.86% |
| Kala Bio inc |
2 Q |
$
-37.23 |
-647.65% |
- |
-686.43% |
| An2 Therapeutics Inc |
2 Q |
$
-37.38 |
-2766.84% |
- |
-47.97% |
| Galectin Therapeutics Inc |
2 Q |
$
-37.47 |
- |
- |
- |
| Zynerba Pharmaceuticals Inc |
2 Q |
$
-37.58 |
- |
- |
-90.03% |
| Benitec Biopharma Inc |
2 Q |
$
-37.92 |
-64266.1% |
- |
-45.28% |
| Aditxt Inc |
2 Q |
$
-37.92 |
-8078.16% |
18.71% |
-1887.97% |
| Amicus Therapeutics inc |
2 Q |
$
-38.10 |
-6.68% |
90.53% |
-19.77% |
| Ovid Therapeutics Inc |
2 Q |
$
-38.18 |
-574.03% |
- |
-58.83% |
| Carisma Therapeutics Inc |
2 Q |
$
-38.28 |
-191.73% |
- |
- |
| Vyne Therapeutics Inc |
2 Q |
$
-38.55 |
-8097.69% |
- |
-77.62% |
| Cartesian Therapeutics Inc |
2 Q |
$
-38.89 |
-566.39% |
- |
- |
| Cue Biopharma Inc |
2 Q |
$
-38.90 |
-469.35% |
- |
-230.13% |
| Citius Pharmaceuticals Inc |
1 Q |
$
-38.92 |
- |
- |
-51.43% |
| Assembly Biosciences Inc |
2 Q |
$
-38.96 |
-117.2% |
- |
-149.01% |
| Casi Pharmaceuticals inc |
4 Q |
$
-39.26 |
-137.57% |
39.06% |
-2120.91% |
| Aravive Inc |
3 Q |
$
-39.85 |
-569.65% |
- |
- |
| Dogwood Therapeutics inc |
3 Q |
$
-39.98 |
- |
- |
-1440.65% |
| Apexigen Inc |
2 Q |
$
-40.04 |
- |
- |
-910.95% |
| Infinity Pharmaceuticals Inc |
2 Q |
$
-40.95 |
-1593.93% |
- |
- |
| Scorpius Holdings inc |
1 Q |
$
-40.96 |
-1392.5% |
10.44% |
-394.59% |
| Jaguar Health Inc |
2 Q |
$
-41.41 |
-350.64% |
81.88% |
-606.71% |
| Prophase Labs Inc |
2 Q |
$
-41.45 |
-421.05% |
20.51% |
-230.18% |
| Rallybio Corporation |
2 Q |
$
-41.65 |
-5745.1% |
- |
-71.66% |
| Rapport Therapeutics Inc |
3 Q |
$
-42.06 |
- |
- |
-12.31% |
| Skye Bioscience Inc |
2 Q |
$
-42.37 |
- |
- |
-68.65% |
| Forte Biosciences Inc |
2 Q |
$
-42.45 |
- |
- |
-85.38% |
| Immutep Limited |
2 Q |
$
-42.72 |
-544.95% |
- |
-22.54% |
| Viracta Therapeutics Inc |
3 Q |
$
-43.29 |
- |
- |
-680.3% |
| Assertio Holdings inc |
2 Q |
$
-43.29 |
-36.97% |
67.87% |
-38.19% |
| Ernexa Therapeutics Inc |
2 Q |
$
-43.70 |
-7509.28% |
83.51% |
- |
| Lifecore Biomedical Inc |
2 Q |
$
-44.17 |
-34.43% |
31.41% |
-1171.85% |
| Aslan Pharmaceuticals Limited |
4 Q |
$
-44.22 |
-368.5% |
- |
- |
| Nanobiotix S a |
4 Q |
$
-44.46 |
-109.65% |
- |
- |
| G1 Therapeutics Inc |
2 Q |
$
-44.77 |
-76.93% |
- |
-136.98% |
| Corvus Pharmaceuticals Inc |
2 Q |
$
-45.14 |
- |
- |
-103.44% |
| Blue Water Vaccines Inc |
2 Q |
$
-45.68 |
-3442.66% |
66.45% |
-307.28% |
| Avalo Therapeutics Inc |
2 Q |
$
-46.22 |
-265.99% |
2.54% |
-48.48% |
| 9 Meters Biopharma Inc |
1 Q |
$
-46.28 |
- |
- |
-584.98% |
| Mustang Bio inc |
2 Q |
$
-46.51 |
- |
- |
-184.12% |
| Arvinas Inc |
1 Q |
$
-46.60 |
-10.92% |
- |
-7.74% |
| Mbx Biosciences Inc |
3 Q |
$
-46.77 |
- |
- |
-17.01% |
| Trevi Therapeutics Inc |
2 Q |
$
-47.30 |
- |
- |
-41.44% |
| Regulus Therapeutics Inc |
1 Q |
$
-47.52 |
-79205% |
- |
-57.53% |
| Inflarx N v |
4 Q |
$
-47.79 |
-67630.69% |
-743.67% |
-41.59% |
| Ars Pharmaceuticals Inc |
2 Q |
$
-48.02 |
-42.74% |
- |
-21.85% |
| Molecular Templates Inc |
2 Q |
$
-48.46 |
-80.35% |
- |
-807.85% |
| Acer Therapeutics Inc |
3 Q |
$
-48.49 |
- |
- |
- |
| Verrica Pharmaceuticals Inc |
2 Q |
$
-48.60 |
-330.52% |
- |
- |
| Mereo Biopharma Group Plc |
2 Q |
$
-49.55 |
-135.89% |
50.89% |
-80% |
| Calliditas Therapeutics Ab |
4 Q |
$
-50.11 |
-38.78% |
95.36% |
-4.97% |
| Traws Pharma inc |
2 Q |
$
-50.56 |
-1742.25% |
- |
- |
| Aldeyra Therapeutics Inc |
2 Q |
$
-50.62 |
- |
- |
-73.63% |
| Climb Bio Inc |
3 Q |
$
-50.75 |
- |
- |
-26.43% |
| Bioxcel Therapeutics Inc |
2 Q |
$
-50.95 |
-5869.82% |
-144.47% |
- |
| Psyence Biomedical ltd |
1 Q |
$
-51.16 |
-7420807.66% |
- |
- |
| Q32 Bio Inc |
2 Q |
$
-52.30 |
-1630.42% |
- |
-2709.7% |
| Rani Therapeutics Holdings Inc |
2 Q |
$
-52.41 |
- |
- |
- |
| Gelesis Holdings Inc |
2 Q |
$
-52.66 |
-433.78% |
-61.4% |
- |
| Dynavax Technologies Corporation |
2 Q |
$
-52.73 |
-16.67% |
82.83% |
-9.16% |
| Igm Biosciences Inc |
2 Q |
$
-53.39 |
- |
- |
-93.35% |
| Spero Therapeutics Inc |
2 Q |
$
-53.60 |
-110.34% |
- |
-120.27% |
| Humanigen Inc |
1 Q |
$
-53.63 |
-3156.8% |
- |
- |
| Ac Immune Sa |
4 Q |
$
-54.23 |
-366.41% |
- |
-33.76% |
| Xilio Therapeutics inc |
2 Q |
$
-54.30 |
-362% |
- |
-385.53% |
| Elicio Therapeutics Inc |
2 Q |
$
-54.61 |
-183.87% |
98.54% |
- |
| Nabriva Therapeutics Plc |
2 Q |
$
-55.05 |
-186.26% |
-15.97% |
-2673.17% |
| Milestone Pharmaceuticals Inc |
2 Q |
$
-55.53 |
- |
- |
-1671.18% |
| Vistagen Therapeutics Inc |
2 Q |
$
-55.78 |
-8634.67% |
- |
-74.06% |
| Ardelyx inc |
2 Q |
$
-56.39 |
-14.6% |
84.8% |
-36.57% |
| Beyondspring Inc |
2 Q |
$
-56.45 |
-4178.53% |
- |
- |
| Checkpoint Therapeutics inc |
1 Q |
$
-56.51 |
-15828.29% |
- |
- |
| Theseus Pharmaceuticals Inc |
3 Q |
$
-56.61 |
- |
- |
-24.84% |
| Corbus Pharmaceuticals Holdings Inc |
2 Q |
$
-57.95 |
-3763.42% |
- |
-43.65% |
| Sarepta Therapeutics Inc |
2 Q |
$
-57.96 |
-2.34% |
- |
-4.42% |
| Evolus Inc |
3 Q |
$
-58.56 |
-15% |
81.98% |
- |
| Propanc Biopharma Inc |
2 Q |
$
-58.92 |
- |
- |
-993.16% |
| Sagimet Biosciences inc |
2 Q |
$
-59.38 |
- |
- |
-39.88% |
| Contineum Therapeutics Inc |
3 Q |
$
-59.39 |
- |
- |
-32.33% |
| Theralink Technologies Inc |
4 Q |
$
-59.58 |
-11649.08% |
72.77% |
- |
| Cybin Inc |
1 Q |
$
-59.81 |
-84.08% |
- |
-26.75% |
| Arcturus Therapeutics Holdings Inc |
2 Q |
$
-60.16 |
-49.27% |
- |
-24.87% |
| Biolinerx Ltd |
4 Q |
$
-60.61 |
-1262.79% |
23.08% |
-458.4% |
| Nextcure Inc |
2 Q |
$
-60.93 |
- |
- |
-107.57% |
| Lakeshore Biopharma Co Ltd |
1 Q |
$
-61.09 |
-75.59% |
79.48% |
-74.07% |
| Shattuck Labs Inc |
2 Q |
$
-61.51 |
-960.11% |
- |
-81.8% |
| Intercept Pharmaceuticals inc |
3 Q |
$
-61.61 |
-21.37% |
99.97% |
-82.24% |
| Boundless Bio Inc |
3 Q |
$
-61.76 |
- |
- |
-47.5% |
| Immuneering Corporation |
2 Q |
$
-62.13 |
-19601.98% |
50.11% |
-146.28% |
| Bolt Biotherapeutics Inc |
1 Q |
$
-63.35 |
-1741.26% |
- |
-96.75% |
| Decibel Therapeutics Inc |
2 Q |
$
-63.39 |
- |
- |
-84.03% |
| Design Therapeutics Inc |
2 Q |
$
-63.49 |
- |
- |
-27.15% |
| Intercure Ltd |
4 Q |
$
-63.53 |
-17.87% |
29.56% |
-13.9% |
| Relmada Therapeutics Inc |
2 Q |
$
-63.58 |
- |
- |
-209.24% |
| Bicara Therapeutics Inc |
2 Q |
$
-64.23 |
- |
- |
-13.55% |
| Perrigo Company Plc |
3 Q |
$
-64.30 |
-1.49% |
36.17% |
-1.45% |
| Kronos Bio Inc |
1 Q |
$
-64.49 |
-701.53% |
- |
-64.22% |
| Satsuma Pharmaceuticals Inc |
1 Q |
$
-64.83 |
- |
- |
-115.24% |
| Alto Neuroscience Inc |
2 Q |
$
-64.86 |
- |
- |
-44.81% |
| Spectrum Pharmaceuticals Inc |
1 Q |
$
-64.97 |
-59.42% |
- |
-209.59% |
| Aquestive Therapeutics Inc |
2 Q |
$
-65.04 |
-147.38% |
61.09% |
- |
| Leap Therapeutics Inc |
2 Q |
$
-65.69 |
-4379% |
- |
-237.65% |
| Paratek Pharmaceuticals Inc |
1 Q |
$
-65.80 |
-39.49% |
84.51% |
- |
| Aptinyx Inc |
1 Q |
$
-66.09 |
-3785.11% |
- |
-157.89% |
| Puretech Health Plc |
4 Q |
$
-66.63 |
-2000.84% |
- |
-14.54% |
| Vanda Pharmaceuticals Inc |
2 Q |
$
-66.94 |
-32.9% |
94.4% |
-12.89% |
| Applied Therapeutics Inc |
2 Q |
$
-67.74 |
-14887.69% |
- |
-231.58% |
| Rvl Pharmaceuticals Plc |
2 Q |
$
-68.27 |
-189.77% |
76.69% |
-155.18% |
| Cti Biopharma Corp |
1 Q |
$
-69.24 |
-91.38% |
94.11% |
- |
| Barinthus Biotherapeutics Plc |
2 Q |
$
-69.50 |
- |
- |
-54.76% |
| Capricor Therapeutics inc |
2 Q |
$
-69.98 |
-314.21% |
- |
-62.71% |
| Onkure Therapeutics Inc |
2 Q |
$
-70.20 |
- |
- |
-81% |
| Kezar Life Sciences Inc |
2 Q |
$
-70.79 |
- |
- |
-63.52% |
| Allakos Inc |
1 Q |
$
-70.85 |
- |
- |
-97.39% |
| Fulcrum Therapeutics Inc |
3 Q |
$
-71.11 |
-663.69% |
- |
-32.17% |
| Foghorn Therapeutics Inc |
3 Q |
$
-72.12 |
-294.16% |
- |
- |
| Rain Oncology Inc |
3 Q |
$
-72.26 |
- |
- |
-82.96% |
| Generation Bio Co |
2 Q |
$
-72.42 |
-341.12% |
- |
-91.07% |
| Werewolf Therapeutics Inc |
3 Q |
$
-72.84 |
-449.05% |
- |
-144.4% |
| Hookipa Pharma inc |
1 Q |
$
-73.31 |
-784.01% |
- |
-120.6% |
| Immunogen inc |
3 Q |
$
-73.52 |
-25.56% |
- |
-22.11% |
| Zymeworks Inc |
2 Q |
$
-73.68 |
-59.96% |
- |
-21.59% |
| Celularity Inc |
2 Q |
$
-73.73 |
-165.35% |
55.1% |
- |
| Mersana Therapeutics inc |
2 Q |
$
-74.04 |
-212.94% |
- |
- |
| Impel Pharmaceuticals Inc |
3 Q |
$
-74.28 |
-903.31% |
-15.55% |
- |
| Rezolute Inc |
2 Q |
$
-74.41 |
- |
- |
-65.03% |
| Intra cellular Therapies Inc |
4 Q |
$
-74.68 |
-10.97% |
- |
-7.4% |
| Applied Molecular Transport Inc |
3 Q |
$
-74.79 |
- |
- |
-223.46% |
| Vaxxinity Inc |
4 Q |
$
-75.22 |
- |
- |
-254.43% |
| Portage Biotech Inc |
1 Q |
$
-75.38 |
- |
- |
-2264.4% |
| Neptune Wellness Solutions Inc |
4 Q |
$
-75.42 |
-192.82% |
1.81% |
- |
| Ligand Pharmaceuticals Incorporated |
2 Q |
$
-75.86 |
-40.48% |
82.37% |
-9.21% |
| Pardes Biosciences Inc |
2 Q |
$
-76.14 |
- |
- |
-43.36% |
| Longboard Pharmaceuticals Inc |
3 Q |
$
-76.34 |
- |
- |
-33.03% |
| Camp4 Therapeutics Corporation |
2 Q |
$
-76.81 |
-26.97% |
38.38% |
- |
| Arca Biopharma Inc |
2 Q |
$
-76.87 |
- |
- |
-28.38% |
| Mirum Pharmaceuticals Inc |
1 Q |
$
-77.34 |
-20.39% |
77.1% |
-33.63% |
| Pmv Pharmaceuticals Inc |
2 Q |
$
-80.87 |
- |
- |
-47.95% |
| Tonix Pharmaceuticals Holding Corp |
2 Q |
$
-81.42 |
-828.22% |
29.27% |
-57.93% |
| Evelo Biosciences Inc |
3 Q |
$
-82.35 |
- |
- |
- |
| Athersys Inc |
3 Q |
$
-83.37 |
-1565.65% |
- |
- |
| Northwest Biotherapeutics Inc |
2 Q |
$
-83.55 |
-7636.93% |
- |
- |
| Vbi Vaccines Inc |
1 Q |
$
-83.99 |
-892.47% |
- |
-1094.9% |
| Neurogene Inc |
2 Q |
$
-84.39 |
- |
- |
-33.33% |
| Zenas Biopharma Inc |
2 Q |
$
-85.80 |
- |
- |
-28.7% |
| Acrivon Therapeutics Inc |
2 Q |
$
-85.96 |
- |
- |
-50.78% |
| Amarin Corp Plcuk |
3 Q |
$
-86.19 |
-38.01% |
38.87% |
-18.3% |
| Reata Pharmaceuticals Inc |
2 Q |
$
-87.62 |
-2781.68% |
- |
- |
| Altimmune inc |
2 Q |
$
-87.75 |
-438730% |
- |
-62.63% |
| Inovio Pharmaceuticals Inc |
2 Q |
$
-87.76 |
-1077.69% |
- |
-158.25% |
| Geron Corp |
2 Q |
$
-88.01 |
-53.68% |
- |
-31.99% |
| Chimerix Inc |
4 Q |
$
-88.39 |
-267.39% |
98.65% |
-60.21% |
| Oculis Holding Ag |
4 Q |
$
-88.80 |
-10056.85% |
- |
-94.74% |
| Oncorus Inc |
1 Q |
$
-90.54 |
- |
- |
-134.31% |
| Korro Bio Inc |
2 Q |
$
-91.36 |
- |
- |
-61.51% |
| Scpharmaceuticals Inc |
2 Q |
$
-91.72 |
-183.55% |
68.46% |
-2086.11% |
| Terns Pharmaceuticals Inc |
2 Q |
$
-91.75 |
- |
- |
-27.35% |
| Enanta Pharmaceuticals Inc |
2 Q |
$
-92.01 |
-141.98% |
- |
-89.02% |
| Evotec Se |
4 Q |
$
-93.98 |
-10.74% |
22.4% |
-7.49% |
| Pepgen Inc |
2 Q |
$
-96.92 |
- |
- |
-92.51% |
| Pyxis Oncology Inc |
3 Q |
$
-97.09 |
- |
- |
-102.12% |
| Atreca inc |
3 Q |
$
-97.76 |
- |
- |
-200.73% |
| Syros Pharmaceuticals Inc |
3 Q |
$
-97.82 |
-417.37% |
- |
-2746.84% |
| Connect Biopharma Holdings Limited |
2 Q |
$
-98.30 |
- |
- |
-113.17% |
| Io Biotech Inc |
1 Q |
$
-98.46 |
- |
- |
-162.55% |
| Larimar Therapeutics Inc |
2 Q |
$
-99.79 |
- |
- |
-62.92% |
| Enliven Therapeutics Inc |
2 Q |
$
-100.22 |
- |
- |
-29.15% |
| Tango Therapeutics Inc |
3 Q |
$
-100.52 |
-151.15% |
- |
-60.8% |
| Zomedica Corp |
1 Q |
$
-101.63 |
-371.23% |
70.78% |
-54.96% |
| Immunic Inc |
2 Q |
$
-101.84 |
- |
- |
-461.46% |
| Janux Therapeutics Inc |
3 Q |
$
-101.90 |
-780.86% |
- |
-10.18% |
| Bioage Labs Inc |
3 Q |
$
-102.36 |
-4713% |
-20.3% |
-33.88% |
| Esperion Therapeutics Inc |
2 Q |
$
-104.02 |
-38.8% |
- |
- |
| Dice Therapeutics Inc |
2 Q |
$
-104.24 |
- |
- |
-22.01% |
| Adlai Nortye Ltd |
4 Q |
$
-104.87 |
-2097.42% |
- |
-132.07% |
| Cymabay Therapeutics Inc |
4 Q |
$
-105.37 |
- |
- |
-50.72% |
| Rapt Therapeutics Inc |
3 Q |
$
-105.64 |
-3251.37% |
- |
-61.81% |
| Tyra Biosciences Inc |
2 Q |
$
-105.83 |
- |
- |
-31.8% |
| Fortress Biotech Inc |
2 Q |
$
-106.52 |
-184.35% |
68.78% |
-767.91% |
| Inozyme Pharma Inc |
1 Q |
$
-106.72 |
- |
- |
-159.97% |
| Nkarta Inc |
2 Q |
$
-109.24 |
- |
- |
-27.74% |
| Repare Therapeutics Inc |
2 Q |
$
-109.86 |
-159.96% |
- |
-78.25% |
| Savara Inc |
2 Q |
$
-110.33 |
- |
- |
-69.05% |
| Wave Life Sciences Ltd |
1 Q |
$
-112.33 |
-107.04% |
- |
-86.49% |
| Dianthus Therapeutics Inc |
2 Q |
$
-114.75 |
-2364.11% |
- |
-34.72% |
| Alx Oncology Holdings Inc |
2 Q |
$
-116.57 |
- |
- |
-115.67% |
| Astria Therapeutics Inc |
2 Q |
$
-116.92 |
- |
- |
-38.63% |
| Adicet Bio Inc |
2 Q |
$
-118.64 |
-306.55% |
- |
-68.48% |
| Affimed N v |
4 Q |
$
-118.65 |
-1280.22% |
- |
-183.26% |
| Ventyx Biosciences Inc |
2 Q |
$
-119.03 |
- |
- |
-48.89% |
| Mural Oncology Plc |
3 Q |
$
-119.10 |
- |
- |
-131.47% |
| Atai Life Sciences N v |
2 Q |
$
-119.51 |
-5175.96% |
- |
-85.51% |
| Nektar Therapeutics |
3 Q |
$
-120.74 |
-192.87% |
87.26% |
-356.81% |
| Liquidia Corporation |
3 Q |
$
-121.85 |
-176.04% |
92.24% |
-296.78% |
| Silence Therapeutics Plc |
3 Q |
$
-122.15 |
-284.25% |
73.93% |
- |
| Omeros Corporation |
2 Q |
$
-122.47 |
- |
- |
- |
| Cassava Sciences Inc |
2 Q |
$
-123.17 |
- |
- |
-93.32% |
| Inventiva S a |
4 Q |
$
-123.68 |
-271.72% |
- |
- |
| Prelude Therapeutics Inc |
2 Q |
$
-124.32 |
- |
- |
-106.5% |
| Precigen Inc |
2 Q |
$
-124.50 |
- |
- |
-1156.79% |
| Karyopharm Therapeutics Inc |
3 Q |
$
-124.62 |
-87.43% |
95.93% |
- |
| Kinnate Biopharma Inc |
3 Q |
$
-127.15 |
- |
- |
-62.31% |
| Pacira Biosciences inc |
2 Q |
$
-127.46 |
-18.06% |
78.19% |
-16.53% |
| Erasca Inc |
2 Q |
$
-128.27 |
- |
- |
-31.19% |
| Marinus Pharmaceuticals Inc |
3 Q |
$
-131.69 |
-416.57% |
91.59% |
- |
| Anaptysbio inc |
2 Q |
$
-132.59 |
-107.66% |
- |
-366.98% |
| Aclaris Therapeutics Inc |
2 Q |
$
-134.65 |
-802.07% |
85.82% |
-95.92% |
| Arrivent Biopharma inc |
2 Q |
$
-136.98 |
- |
- |
-55.48% |
| Oric Pharmaceuticals Inc |
2 Q |
$
-137.25 |
- |
- |
-51.75% |
| Compass Pathways Plc |
2 Q |
$
-138.10 |
- |
- |
-78.27% |
| Day One Biopharmaceuticals Inc |
2 Q |
$
-138.23 |
-73.67% |
- |
-27.67% |
| Biomea Fusion Inc |
2 Q |
$
-138.43 |
- |
- |
-301.27% |
| Septerna Inc |
2 Q |
$
-138.64 |
-9811.39% |
- |
-49.94% |
| Olema Pharmaceuticals Inc |
2 Q |
$
-142.30 |
- |
- |
-42.59% |
| Ngm Biopharmaceuticals Inc |
4 Q |
$
-142.38 |
-3223.34% |
- |
-77.85% |
| Atea Pharmaceuticals Inc |
2 Q |
$
-143.51 |
- |
- |
-33.95% |
| Arbutus Biopharma Corp |
1 Q |
$
-146.49 |
-2287.85% |
- |
-144.37% |
| Upstream Bio Inc |
3 Q |
$
-147.80 |
-3742.67% |
- |
-34.72% |
| Amylyx Pharmaceuticals Inc |
3 Q |
$
-149.28 |
-75.98% |
41.44% |
-68.95% |
| Prometheus Biosciences Inc |
1 Q |
$
-150.56 |
-3768.76% |
- |
-33.5% |
| Avid Bioservices Inc |
3 Q |
$
-152.05 |
-101% |
7.67% |
-176.54% |
| Blueprint Medicines Corporation |
1 Q |
$
-155.73 |
-27.7% |
96.48% |
-48.89% |
| Gossamer Bio Inc |
3 Q |
$
-156.16 |
-354.5% |
- |
- |
| Edgewise Therapeutics inc |
3 Q |
$
-157.24 |
- |
- |
-30.88% |
| Arrowhead Pharmaceuticals Inc |
2 Q |
$
-159.35 |
-57.25% |
- |
-43.92% |
| Mallinckrodt Plc |
1 Q |
$
-162.60 |
-8.53% |
41.08% |
-13.55% |
| Teva Pharmaceutical Industries Limited |
2 Q |
$
-163.00 |
-0.98% |
49.6% |
-2.62% |
| Verona Pharma Plc |
1 Q |
$
-163.94 |
- |
- |
-89.84% |
| Urogen Pharma Ltd |
3 Q |
$
-164.64 |
-171.7% |
88.53% |
- |
| Abivax Sa |
4 Q |
$
-165.47 |
- |
- |
-75.37% |
| Abcellera Biologics Inc |
2 Q |
$
-165.67 |
-503.92% |
- |
-15.91% |
| Verastem Inc |
2 Q |
$
-166.56 |
-4571.92% |
- |
- |
| Adc Therapeutics Sa |
2 Q |
$
-169.94 |
-220% |
92.3% |
- |
| Xencor Inc |
2 Q |
$
-173.10 |
-117.81% |
- |
-26.23% |
| Lexicon Pharmaceuticals Inc |
1 Q |
$
-177.30 |
-568.04% |
98.03% |
-103.16% |
| Lunai Bioworks Inc |
2 Q |
$
-178.01 |
- |
- |
-288.06% |
| Morphic Holding inc |
2 Q |
$
-179.83 |
-238.82% |
- |
-26.62% |
| Opko Health Inc |
3 Q |
$
-180.40 |
-28.1% |
24.41% |
-13.67% |
| Verve Therapeutics Inc |
1 Q |
$
-181.01 |
-303.64% |
- |
-35.82% |
| Disc Medicine Inc |
3 Q |
$
-181.11 |
- |
- |
-31.61% |
| Immunome Inc |
2 Q |
$
-181.50 |
-1654.1% |
- |
-126.31% |
| Structure Therapeutics Inc |
3 Q |
$
-183.00 |
- |
- |
-21.81% |
| Rhythm Pharmaceuticals inc |
2 Q |
$
-188.44 |
-120.57% |
89.25% |
-1885.18% |
| Annexon Inc |
2 Q |
$
-188.78 |
- |
- |
-70.74% |
| Deciphera Pharmaceuticals Inc |
1 Q |
$
-190.42 |
-108.87% |
96.95% |
-52.42% |
| Mineralys Therapeutics Inc |
2 Q |
$
-190.77 |
- |
- |
-70.44% |
| Schrodinger Inc |
1 Q |
$
-192.21 |
-83.13% |
62.42% |
-44.74% |
| Kalvista Pharmaceuticals Inc |
2 Q |
$
-203.10 |
-1600.45% |
- |
-195.62% |
| Spyre Therapeutics Inc |
2 Q |
$
-206.81 |
-3562.69% |
- |
-46.38% |
| Pliant Therapeutics Inc |
2 Q |
$
-206.96 |
-2101.77% |
- |
-73.45% |
| Morphosys Ag |
4 Q |
$
-212.50 |
-79.63% |
75.51% |
-386.82% |
| Zai Lab Limited |
2 Q |
$
-212.52 |
-49.68% |
- |
-27.32% |
| Moonlake Immunotherapeutics |
3 Q |
$
-213.70 |
- |
- |
-56.42% |
| Kura Oncology Inc |
3 Q |
$
-216.88 |
-208.48% |
- |
-65.42% |
| Nuvation Bio Inc |
3 Q |
$
-217.48 |
-820.28% |
54.74% |
-54.99% |
| Uniqure N v |
1 Q |
$
-217.58 |
-1077.05% |
93.5% |
-483.87% |
| Vera Therapeutics Inc |
2 Q |
$
-218.28 |
- |
- |
-46.7% |
| Iveric Bio Inc |
1 Q |
$
-222.90 |
- |
- |
-57% |
| Zentalis Pharmaceuticals Inc |
1 Q |
$
-224.19 |
- |
- |
-65.48% |
| Travere Therapeutics Inc |
1 Q |
$
-226.71 |
-82.88% |
96.01% |
-1183.97% |
| Axsome Therapeutics Inc |
3 Q |
$
-231.93 |
-38.13% |
92.18% |
-360.95% |
| 23andme Holding Co |
2 Q |
$
-235.31 |
-135.22% |
53.45% |
-990.3% |
| Viking Therapeutics Inc |
3 Q |
$
-237.39 |
- |
- |
-29.35% |
| Newamsterdam Pharma Company N v |
3 Q |
$
-237.72 |
-674.52% |
- |
-31.26% |
| Centessa Pharmaceuticals Plc |
3 Q |
$
-242.70 |
- |
- |
-67.68% |
| Nurix Therapeutics Inc |
3 Q |
$
-244.79 |
-292.5% |
- |
-53.57% |
| Chinook Therapeutics Inc |
2 Q |
$
-245.65 |
-4199.93% |
- |
-58.28% |
| Ocular Therapeutix Inc |
3 Q |
$
-249.67 |
-447.57% |
88.87% |
-87.19% |
| Bicycle Therapeutics Plc |
3 Q |
$
-250.66 |
-884.51% |
- |
-35.54% |
| Rocket Pharmaceuticals Inc |
2 Q |
$
-257.30 |
- |
- |
-66% |
| Sinovac Biotech Ltd |
4 Q |
$
-258.36 |
-57.7% |
59.58% |
-2.15% |
| Eqrx Inc |
3 Q |
$
-259.62 |
- |
- |
-20.27% |
| Acelyrin Inc |
1 Q |
$
-268.52 |
- |
- |
-54.74% |
| Praxis Precision Medicines Inc |
3 Q |
$
-273.04 |
-3192.28% |
- |
-66.9% |
| Lannett Company Inc |
1 Q |
$
-274.29 |
-94.78% |
13.81% |
- |
| Phathom Pharmaceuticals Inc |
3 Q |
$
-274.55 |
-186.53% |
87.25% |
- |
| Akero Therapeutics Inc |
2 Q |
$
-283.96 |
- |
- |
-31.57% |
| Cogent Biosciences Inc |
2 Q |
$
-284.08 |
-3609.15% |
- |
-120.25% |
| Madrigal Pharmaceuticals Inc |
3 Q |
$
-289.13 |
-39.04% |
99.16% |
-41.5% |
| Curevac N v |
4 Q |
$
-291.39 |
-483.96% |
-131.34% |
-50.33% |
| Sage Therapeutics Inc |
2 Q |
$
-301.20 |
-427.77% |
- |
-67.1% |
| Prothena Corporation Public Limited Company |
2 Q |
$
-302.92 |
-2929.3% |
- |
-67.95% |
| Xenon Pharmaceuticals Inc |
3 Q |
$
-306.33 |
-2325.82% |
- |
-46.2% |
| Ionis Pharmaceuticals Inc |
3 Q |
$
-318.52 |
-33.84% |
98.94% |
-72.44% |
| Alnylam Pharmaceuticals Inc |
2 Q |
$
-319.09 |
-12.96% |
83.88% |
-274.21% |
| Lyell Immunopharma Inc |
2 Q |
$
-331.40 |
-552328.33% |
- |
-85.58% |
| Ideaya Biosciences Inc |
2 Q |
$
-331.80 |
-665.32% |
- |
-31.43% |
| Syndax Pharmaceuticals Inc |
2 Q |
$
-334.99 |
-428.48% |
- |
-130.47% |
| Maravai Lifesciences Holdings Inc |
2 Q |
$
-345.14 |
-159.9% |
29.11% |
-63.08% |
| Crinetics Pharmaceuticals Inc |
2 Q |
$
-369.83 |
-7243.13% |
- |
-32.28% |
| Merus N v |
3 Q |
$
-381.14 |
-673.31% |
- |
-53.29% |
| Nuvalent Inc |
3 Q |
$
-381.44 |
-9010.99% |
77.72% |
-39.47% |
| Karuna Therapeutics Inc |
3 Q |
$
-396.07 |
-3507.82% |
- |
-29.58% |
| Jazz Pharmaceuticals Plc |
2 Q |
$
-404.84 |
-9.91% |
- |
-10.03% |
| Dyne Therapeutics Inc |
2 Q |
$
-412.89 |
- |
- |
-64.12% |
| Catalent Inc |
3 Q |
$
-413.00 |
-9.34% |
21.82% |
-11.44% |
| Arcus Biosciences Inc |
3 Q |
$
-433.00 |
-338.28% |
- |
-85.87% |
| 89bio Inc |
2 Q |
$
-450.21 |
- |
- |
-94.48% |
| Cerevel Therapeutics Holdings Inc |
1 Q |
$
-460.47 |
- |
- |
-98.94% |
| Avidity Biosciences Inc |
2 Q |
$
-474.18 |
-4762.73% |
- |
-34.8% |
| Legend Biotech Corporation |
4 Q |
$
-518.25 |
-181.75% |
49.42% |
-41.41% |
| Ultragenyx Pharmaceutical Inc |
3 Q |
$
-579.83 |
-91.95% |
84.69% |
-414.17% |
| Cytokinetics Incorporated |
2 Q |
$
-606.31 |
-707.17% |
- |
- |
| Roivant Sciences Ltd |
2 Q |
$
-688.14 |
-705.38% |
-24.51% |
-13.03% |
| Mirati Therapeutics Inc |
3 Q |
$
-725.88 |
-1900.65% |
- |
-82.15% |
| Biohaven Ltd |
2 Q |
$
-766.97 |
-89.22% |
85.63% |
-270.65% |
| Bridgebio Pharma Inc |
3 Q |
$
-805.69 |
-227.74% |
95.78% |
- |
| Summit Therapeutics Inc |
3 Q |
$
-921.62 |
-44223.46% |
- |
-311.15% |
| Insmed Inc |
3 Q |
$
-1,183.84 |
-346.05% |
69.35% |
-183.55% |
| Endo International Plc |
4 Q |
$
-2,449.81 |
-121.79% |
52.95% |
- |
| Viatris Inc |
2 Q |
$
-3,468.30 |
-24.57% |
36.61% |
-19.92% |
